90 related articles for article (PubMed ID: 7066260)
1. Levels of circulating immune complexes in patients with ovarian cancer.
Clarke AG; Vasey DP; Symonds EM; Faratian B; McLaughlin PJ; Price MR; Baldwin RW
Br J Obstet Gynaecol; 1982 Mar; 89(3):231-7. PubMed ID: 7066260
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes in ovarian carcinoma.
Runowicz CD; Cohen CJ; Adelsberg BR
Gynecol Oncol; 1989 Mar; 32(3):350-3. PubMed ID: 2920956
[TBL] [Abstract][Full Text] [Related]
3. Analysis of sera from ovarian cancer patients for immune complexes.
Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T
J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047
[TBL] [Abstract][Full Text] [Related]
4. Immunologic approaches to the management of ovarian carcinoma.
Bast RC; Knapp RC
Semin Oncol; 1984 Sep; 11(3):264-74. PubMed ID: 6207593
[No Abstract] [Full Text] [Related]
5. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
6. The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes.
Dodd J; Tyler JP; Crandon AJ; Blumenthal NJ; Fay RA; Baird PJ; Hicks LJ; Hudson CN
Br J Obstet Gynaecol; 1985 Oct; 92(10):1054-60. PubMed ID: 3863669
[TBL] [Abstract][Full Text] [Related]
7. [Sequential determination of circulating immune complexes in ovarian tumors].
Beaufort F; Auner H; Lahousen M
Wien Med Wochenschr; 1986 Jul; 136(13):317-22. PubMed ID: 3765649
[TBL] [Abstract][Full Text] [Related]
8. A sequential study of humoral factors in ovarian neoplasms.
Gupta SC; Agarwal J; Singh PA; Mehdiratta NK; Keswani NK
Indian J Pathol Microbiol; 1994 Jul; 37(3):319-26. PubMed ID: 7814065
[TBL] [Abstract][Full Text] [Related]
9. Tumour markers with unknown functions in gynaecological neoplasia.
Price MR; McLaughlin PJ; Robins RA; Baldwin RW; Vasey D; Symonds EM
Arch Gynecol; 1980; 229(4):325-31. PubMed ID: 7416810
[TBL] [Abstract][Full Text] [Related]
10. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
[TBL] [Abstract][Full Text] [Related]
12. Identification of acute-phase proteins (APP) in circulating immune complexes (CIC) in esophageal cancer patients' sera.
Croce MV; Segal-Eiras A
Cancer Invest; 1996; 14(5):421-6. PubMed ID: 8816857
[TBL] [Abstract][Full Text] [Related]
13. The nature of immune complexes in human cancer sera.
Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
[TBL] [Abstract][Full Text] [Related]
14. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
15. Immune complexes in ovarian cancer.
Clayton LA; Gall SA; Dawson JR; Creasman WT
Gynecol Oncol; 1982 Apr; 13(2):203-12. PubMed ID: 7076036
[No Abstract] [Full Text] [Related]
16. Detection of circulating immune complexes in gynecological malignancies.
Neri B; Comparini T; Brogioni M; Chieffi O; Fabbiani M
Eur J Gynaecol Oncol; 1983; 4(1):37-40. PubMed ID: 6345162
[TBL] [Abstract][Full Text] [Related]
17. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
18. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
[TBL] [Abstract][Full Text] [Related]
19. Protective role of BCG in the rabbit model of mesangial proliferative glomerulonephritis.
Xu JJ; Qian TS; Xin CY; Wu YJ; Huang ZC
Nephrol Dial Transplant; 1991; 6(8):554-6. PubMed ID: 1956554
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma.
Ruell P; Murray E; McCarthy WH; Hersey P
Oncodev Biol Med; 1982; 3(1):1-12. PubMed ID: 6981802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
